Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-23

Clinical Trial Update: Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children

View source ↗

Summary

This trial update evaluates whether reduced pneumococcal conjugate vaccine dosing schedules maintain immunogenicity in South African children, with focus on pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: University of Witwatersrand, South Africa | Conditions: Pneumonia, Meningitis | Status: COMPLETED